- Home
- HIO vs LFCR Comparison
HIO vs LFCR Comparison
Compare HIO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- LFCR
- Stock Information
- Founded
- HIO 1993
- LFCR 1986
- Country
- HIO United States
- LFCR United States
- Employees
- HIO N/A
- LFCR N/A
- Industry
- HIO Finance/Investors Services
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- LFCR Health Care
- Exchange
- HIO Nasdaq
- LFCR Nasdaq
- Market Cap
- HIO 380.4M
- LFCR 308.8M
- IPO Year
- HIO N/A
- LFCR N/A
- Fundamental
- Price
- HIO $3.98
- LFCR $7.49
- Analyst Decision
- HIO
- LFCR Buy
- Analyst Count
- HIO 0
- LFCR 4
- Target Price
- HIO N/A
- LFCR $8.00
- AVG Volume (30 Days)
- HIO 305.3K
- LFCR 227.7K
- Earning Date
- HIO 01-01-0001
- LFCR 08-25-2025
- Dividend Yield
- HIO 10.33%
- LFCR N/A
- EPS Growth
- HIO N/A
- LFCR N/A
- EPS
- HIO N/A
- LFCR N/A
- Revenue
- HIO N/A
- LFCR $130,309,000.00
- Revenue This Year
- HIO N/A
- LFCR $1.64
- Revenue Next Year
- HIO N/A
- LFCR $2.91
- P/E Ratio
- HIO N/A
- LFCR N/A
- Revenue Growth
- HIO N/A
- LFCR 7.23
- 52 Week Low
- HIO $3.52
- LFCR $3.68
- 52 Week High
- HIO $4.03
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- HIO 58.50
- LFCR 45.48
- Support Level
- HIO $3.97
- LFCR $8.10
- Resistance Level
- HIO $3.94
- LFCR $8.85
- Average True Range (ATR)
- HIO 0.03
- LFCR 0.38
- MACD
- HIO -0.00
- LFCR -0.12
- Stochastic Oscillator
- HIO 72.22
- LFCR 0.73
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.